Related Experiment Video
Updated: Feb 14, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Recent progress in potential anti-hepatitis B virus agents: Structural and pharmacological perspectives
Dejuan Sun1, Lingjuan Zhu1, Dahong Yao1
1Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Hepatitis B virus (HBV) infection treatments face challenges due to low response rates and side effects. This review analyzes approved and novel anti-HBV drugs, exploring their mechanisms to guide future antiviral discovery.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis B virus (HBV) infections impact 240 million globally, leading to liver cirrhosis and cancer.
- Annual mortality from HBV-related liver damage is estimated at 686,000.
- Current treatments include interferon (IFN) and nucleos(t)ide analogs, but face limitations.
Purpose of the Study:
- To summarize currently approved anti-HBV drugs.
- To characterize novel HBV inhibitors, including their structures, targets, and mechanisms.
- To provide insights for discovering new small-molecule anti-HBV therapeutics.
Main Methods:
- Literature review of approved antiviral drugs for hepatitis B.
- Analysis of structural and mechanistic data for novel HBV inhibitors.
- Evaluation of anti-HBV effects and drug resistance profiles.
Main Results:
- Approved drugs like IFN and nucleos(t)ide analogs have limited efficacy and potential side effects.
- Novel inhibitors are being investigated for improved efficacy and safety profiles.
- Understanding drug mechanisms is crucial for overcoming resistance.
Conclusions:
- Developing effective and safe treatments for HBV remains a significant challenge.
- Further research into novel HBV inhibitors is essential for advancing hepatitis B therapy.
- This review highlights pathways for discovering next-generation anti-HBV compounds.
Related Concept Videos
What are Viruses?
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Social Cognitive Perspective on Personality
Viral Structure
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...

